...
shph-img

Shuttle Pharmaceuticals Inc, Common Stock

SHPH

NAQ

$0.6847

-$0.02

(-2.86%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.72M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
67.71K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.74
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.68 L
$4.94 H
$0.6847

About Shuttle Pharmaceuticals Inc, Common Stock

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameSHPHSectorS&P500
1-Week Return-8.46%-2.27%-0.57%
1-Month Return-38.32%-3.96%1.21%
3-Month Return-59.72%-9.7%7.57%
6-Month Return-80.5%-3.37%11.45%
1-Year Return-81.75%3.71%28.48%
3-Year Return-99.78%3.8%29.52%

Financials

Dec '18Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-54.95K60.83K66.83K6.81K[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":82.22,"profit":true},{"date":"2021-12-31","value":91.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":10.19,"profit":true}]
Gross Profit-(54.95K)(60.83K)(66.83K)(6.81K)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-5495100,"profit":false},{"date":"2021-12-31","value":-6083400,"profit":false},{"date":"2022-12-31","value":-6683200,"profit":false},{"date":"2023-12-31","value":-681100,"profit":false}]
Gross Margin-----[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses-509.52K1.74M2.55M5.89M[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":8.66,"profit":true},{"date":"2021-12-31","value":29.61,"profit":true},{"date":"2022-12-31","value":43.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income-(509.52K)(1.74M)(2.55M)(5.89M)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-50952200,"profit":false},{"date":"2021-12-31","value":-174299200,"profit":false},{"date":"2022-12-31","value":-255427800,"profit":false},{"date":"2023-12-31","value":-589238000,"profit":false}]
Total Non-Operating Income/Expense-(335.84K)540.07K(1.44M)(2.72M)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-62.18,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-267.38,"profit":false},{"date":"2023-12-31","value":-503.08,"profit":false}]
Pre-Tax Income-(805.73K)(1.15M)(3.03M)(6.59M)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-80573200,"profit":false},{"date":"2021-12-31","value":-115213400,"profit":false},{"date":"2022-12-31","value":-302844800,"profit":false},{"date":"2023-12-31","value":-659272300,"profit":false}]
Income Taxes-39.63K50.79K71.01K(1.00)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":55.81,"profit":true},{"date":"2021-12-31","value":71.52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes-(845.36K)(1.20M)(3.10M)(6.59M)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-84536200,"profit":false},{"date":"2021-12-31","value":-120292200,"profit":false},{"date":"2022-12-31","value":-309945700,"profit":false},{"date":"2023-12-31","value":-659272200,"profit":false}]
Income From Continuous Operations-(805.73K)(1.15M)(3.03M)(5.70M)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-80573200,"profit":false},{"date":"2021-12-31","value":-115213400,"profit":false},{"date":"2022-12-31","value":-302844800,"profit":false},{"date":"2023-12-31","value":-570313200,"profit":false}]
Income From Discontinued Operations-----[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income-(845.36K)(1.20M)(3.10M)(6.59M)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-84536200,"profit":false},{"date":"2021-12-31","value":-120292200,"profit":false},{"date":"2022-12-31","value":-309945700,"profit":false},{"date":"2023-12-31","value":-659272300,"profit":false}]
EPS (Diluted)---(0.14)(3.52)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-14,"profit":false},{"date":"2023-12-31","value":-352.5,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SHPH
Cash Ratio 0.09
Current Ratio 0.22

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SHPH
ROA (LTM) -61.69%
ROE (LTM) -186.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SHPH
Debt Ratio Lower is generally better. Negative is bad. 2.95
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.95

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SHPH
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 4.16
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Shuttle Pharmaceuticals Inc share price today?

Shuttle Pharmaceuticals Inc (SHPH) share price today is $0.6847

Can Indians buy Shuttle Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Shuttle Pharmaceuticals Inc (SHPH) on Vested. To buy Shuttle Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SHPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Shuttle Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Shuttle Pharmaceuticals Inc (SHPH) via the Vested app. You can start investing in Shuttle Pharmaceuticals Inc (SHPH) with a minimum investment of $1.

How to invest in Shuttle Pharmaceuticals Inc shares from India?

You can invest in shares of Shuttle Pharmaceuticals Inc (SHPH) via Vested in three simple steps:

  • Click on Sign Up or Invest in SHPH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Shuttle Pharmaceuticals Inc shares
What is Shuttle Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Shuttle Pharmaceuticals Inc (SHPH) is $4.94. The 52-week low price of Shuttle Pharmaceuticals Inc (SHPH) is $0.68.

What is Shuttle Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Shuttle Pharmaceuticals Inc (SHPH) is

What is Shuttle Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Shuttle Pharmaceuticals Inc (SHPH) is 4.16

What is Shuttle Pharmaceuticals Inc dividend yield?

The dividend yield of Shuttle Pharmaceuticals Inc (SHPH) is 0.00%

What is the Market Cap of Shuttle Pharmaceuticals Inc?

The market capitalization of Shuttle Pharmaceuticals Inc (SHPH) is $2.72M

What is Shuttle Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Shuttle Pharmaceuticals Inc is SHPH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top